Sector ratings Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.56 USD | +6.04% |
|
+6.60% | +56.63% |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark | CI |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 2.07B | - | B | - | - | ||||
| 49.18B | AAA | |||||||
| 39.58B | - | B | - | - | ||||
| 34.69B | - | |||||||
| 34.42B | AAA | |||||||
| 27.11B | A | |||||||
| 16.21B | - | - | - | - | ||||
| 15.36B | BBB | |||||||
| 14.05B | AA | |||||||
| 13.02B | AAA | |||||||
| 11.76B | - | BBB | - | - | ||||
| 11.24B | AA | |||||||
| 10.81B | AA | |||||||
| 10.04B | - | B | - | - | ||||
| 9.52B | - | BBB | - | - | ||||
| 9.42B | A | - | ||||||
| 9.06B | BB | - | ||||||
| 8.99B | - | A | - | - | ||||
| 8.8B | AA | |||||||
| 8.79B | A | |||||||
| Average | 17.21B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector ratings
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
